Rates of Secondary Bladder and Rectal Cancers After External Beam Radiation for Prostate Cancer According to Age and D’amico Risk Groups in A Contemporary Cohort

IF 2.4 3区 医学 Q3 ONCOLOGY
Clinical genitourinary cancer Pub Date : 2025-12-01 Epub Date: 2025-09-09 DOI:10.1016/j.clgc.2025.102429
Mario de Angelis , Carolin Siech , Letizia Maria Ippolita Jannello , Francesco Di Bello , Natali Rodriguez Peñaranda , Pietro Scilipoti , Mattia Longoni , Jordan A. Goyal , Zhe Tian , Nicola Longo , Ottavio de Cobelli , Gennaro Musi , Felix K.H. Chun , Stefano Puliatti , Fred Saad , Shahrokh F. Shariat , Giorgio Gandaglia , Marco Moschini , Francesco Montorsi , Alberto Briganti , Pierre I. Karakiewicz
{"title":"Rates of Secondary Bladder and Rectal Cancers After External Beam Radiation for Prostate Cancer According to Age and D’amico Risk Groups in A Contemporary Cohort","authors":"Mario de Angelis ,&nbsp;Carolin Siech ,&nbsp;Letizia Maria Ippolita Jannello ,&nbsp;Francesco Di Bello ,&nbsp;Natali Rodriguez Peñaranda ,&nbsp;Pietro Scilipoti ,&nbsp;Mattia Longoni ,&nbsp;Jordan A. Goyal ,&nbsp;Zhe Tian ,&nbsp;Nicola Longo ,&nbsp;Ottavio de Cobelli ,&nbsp;Gennaro Musi ,&nbsp;Felix K.H. Chun ,&nbsp;Stefano Puliatti ,&nbsp;Fred Saad ,&nbsp;Shahrokh F. Shariat ,&nbsp;Giorgio Gandaglia ,&nbsp;Marco Moschini ,&nbsp;Francesco Montorsi ,&nbsp;Alberto Briganti ,&nbsp;Pierre I. Karakiewicz","doi":"10.1016/j.clgc.2025.102429","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>External beam radiation therapy (EBRT) predisposes to radiation-induced bladder (BCa) and/or rectal cancer (RCa). This risk may have declined with modern radiation techniques. Moreover, it remains unclear whether the risk varies by age or D’Amico risk classification.</div></div><div><h3>Materials and Methods</h3><div>Within the Surveillance, Epidemiology, and End Results database (2004-2020), we identified patients who were treated with either EBRT or radical prostatectomy (RP) for prostate cancer. Cumulative incidence plots and competing risks regression (CRR) models were fitted. Subgroup analyses were performed according to year of diagnosis (contemporary: 2012-2020 vs. historical: 2004-2011 cohorts), age (&lt; 65 vs. ≥ 65) and D’Amico risk groups.</div></div><div><h3>Results</h3><div>Of 251,838, 110,239 (44%) underwent EBRT versus 141,599 RP (56%). Relative to RP patients, EBRT was associated with a two-fold higher 10-year incidence of secondary BCa (0.9 versus 1.9%, respectively). In multivariable CRR models, EBRT was associated with higher risk of BCa (HR: 1.5, 95% CI: 1.3-1.6, <em>P</em> &lt; .001). Similarly, relative to RP, EBRT was also associated with two-fold higher 10-year incidence of secondary RCa (0.8 versus 1.5%, respectively). In multivariable CRR models, EBRT was associated with higher risk of RCa (HR: 1.4, 95% CI: 1.2-1.5, <em>P</em> &lt; .001). In subgroup analyses, the 5-year EBRT–RP absolute difference in secondary RCa was lower in the contemporary cohort (0.2%) than in the historical cohort (0.5%), whereas no such reduction was observed for BCa. In subgroup analyses according to D’Amico risk groups and age, no clinically significant differences were recorded.</div></div><div><h3>Conclusion</h3><div>EBRT is associated with higher risk of both BCa and RCa as compared to RP. In contemporary EBRT patients, secondary RCa rate is lower, but not BCa rate. D’Amico risk groups as well as age categories did not affect either secondary BCa or secondary RCa rates.</div></div>","PeriodicalId":10380,"journal":{"name":"Clinical genitourinary cancer","volume":"23 6","pages":"Article 102429"},"PeriodicalIF":2.4000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical genitourinary cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1558767325001296","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

External beam radiation therapy (EBRT) predisposes to radiation-induced bladder (BCa) and/or rectal cancer (RCa). This risk may have declined with modern radiation techniques. Moreover, it remains unclear whether the risk varies by age or D’Amico risk classification.

Materials and Methods

Within the Surveillance, Epidemiology, and End Results database (2004-2020), we identified patients who were treated with either EBRT or radical prostatectomy (RP) for prostate cancer. Cumulative incidence plots and competing risks regression (CRR) models were fitted. Subgroup analyses were performed according to year of diagnosis (contemporary: 2012-2020 vs. historical: 2004-2011 cohorts), age (< 65 vs. ≥ 65) and D’Amico risk groups.

Results

Of 251,838, 110,239 (44%) underwent EBRT versus 141,599 RP (56%). Relative to RP patients, EBRT was associated with a two-fold higher 10-year incidence of secondary BCa (0.9 versus 1.9%, respectively). In multivariable CRR models, EBRT was associated with higher risk of BCa (HR: 1.5, 95% CI: 1.3-1.6, P < .001). Similarly, relative to RP, EBRT was also associated with two-fold higher 10-year incidence of secondary RCa (0.8 versus 1.5%, respectively). In multivariable CRR models, EBRT was associated with higher risk of RCa (HR: 1.4, 95% CI: 1.2-1.5, P < .001). In subgroup analyses, the 5-year EBRT–RP absolute difference in secondary RCa was lower in the contemporary cohort (0.2%) than in the historical cohort (0.5%), whereas no such reduction was observed for BCa. In subgroup analyses according to D’Amico risk groups and age, no clinically significant differences were recorded.

Conclusion

EBRT is associated with higher risk of both BCa and RCa as compared to RP. In contemporary EBRT patients, secondary RCa rate is lower, but not BCa rate. D’Amico risk groups as well as age categories did not affect either secondary BCa or secondary RCa rates.
前列腺癌体外放射治疗后继发膀胱癌和直肠癌的发病率与年龄和D'amico风险组的关系
背景:外束放射治疗(EBRT)易导致辐射诱发膀胱癌(BCa)和/或直肠癌(RCa)。随着现代辐射技术的发展,这种风险可能已经降低。此外,尚不清楚风险是否随年龄或D'Amico风险分类而变化。材料和方法:在监测、流行病学和最终结果数据库(2004-2020)中,我们确定了接受EBRT或根治性前列腺切除术(RP)治疗前列腺癌的患者。拟合了累积发生率图和竞争风险回归(CRR)模型。根据诊断年份(当代:2012-2020 vs历史:2004-2011队列)、年龄(< 65 vs≥65)和D'Amico风险组进行亚组分析。结果:在251,838例患者中,110,239例(44%)接受了EBRT,而141,599例(56%)接受了RP。与RP患者相比,EBRT与10年继发性BCa发生率高两倍相关(分别为0.9%和1.9%)。在多变量CRR模型中,EBRT与BCa的高风险相关(HR: 1.5, 95% CI: 1.3-1.6, P < 0.001)。同样,相对于RP, EBRT也与10年继发性RCa发生率高两倍相关(分别为0.8%和1.5%)。在多变量CRR模型中,EBRT与较高的RCa风险相关(HR: 1.4, 95% CI: 1.2-1.5, P < 0.001)。在亚组分析中,继发性RCa的5年EBRT-RP绝对差异在当代队列中(0.2%)低于历史队列(0.5%),而在BCa中没有观察到这种降低。在根据D'Amico危险组和年龄进行的亚组分析中,无临床显著性差异。结论:与RP相比,EBRT与BCa和RCa的风险均较高。在当代EBRT患者中,继发性RCa发生率较低,但BCa发生率不低。D'Amico风险组和年龄类别对继发性BCa和继发性RCa发生率没有影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical genitourinary cancer
Clinical genitourinary cancer 医学-泌尿学与肾脏学
CiteScore
5.20
自引率
6.20%
发文量
201
审稿时长
54 days
期刊介绍: Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书